, Nov. 19, 2019
/PRNewswire/ -- XSOLIS, the company channeling health care data into predictive intelligence and action, today announced that it has acquired MEDarchon, a provider of intelligent clinical communication.
-based MEDarchon was founded in 2012 with a specific goal in mind: to improve patient care and provider effectiveness by preventing silos in communication. MEDarchon offers real-time, unified clinical communication to better care delivery. Similarly, XSOLIS uses real-time clinical data and analytics to better healthcare operations. "XSOLIS offers MEDarchon a partner equally dedicated to innovation and forward momentum," said Joan Butters
, CEO and cofounder of XSOLIS. "Together, our two companies envision a future where real-time data can inform real-time communication to build a smarter future for healthcare."
The acquisition was finalized on November 15, 2019
. The financial terms of the deal were not disclosed. MEDarchon clients will experience no immediate change in service or support. "We are thrilled to join XSOLIS as a part of our journey," said Lyle Beasley
, MEDarchon Board Member. "We believe our clients will benefit immensely from the opportunities XSOLIS offers in product and solution development."
XSOLIS is a healthcare technology firm focused on improving healthcare operations through cognitive computing. Partnering with some of the most forward-thinking healthcare organizations across the nation, XSOLIS transforms the utilization management process between payers and providers; XSOLIS analytics form the common framework for objective, holistic determinations of medical necessity. For more information, visit www.xsolis.com.
View original content:http://www.prnewswire.com/news-releases/xsolis-announces-acquisition-of-medarchon-300957909.html